T2 Biosystems Inc EV/EBITDA
What is the EV/EBITDA of T2 Biosystems Inc?
The EV/EBITDA of T2 Biosystems Inc is N/A
What is the definition of EV/EBITDA?
EV/EBITDA is enterprise value divided by earnings before interest, tax, depreciation, and amortization. It is a measure of how expensive a stock is and is more frequently valid for comparisons across companies than the price to earnings ratio. It measures the price (in the form of enterprise value) an investor pays for the benefit of the company’s cash flow (in the form of EBITDA).
= enterprise value / EBITDA
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA of companies in the Health Care sector on NASDAQ compared to T2 Biosystems Inc
What does T2 Biosystems Inc do?
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
Companies with ev/ebitda similar to T2 Biosystems Inc
- Prime Intelligence Solutions has EV/EBITDA of N/A
- K.B. Recycling Industries has EV/EBITDA of N/A
- Forward Water Technologies has EV/EBITDA of N/A
- Fjordland Exploration has EV/EBITDA of N/A
- Aquarius AI has EV/EBITDA of N/A
- Sipa Resources has EV/EBITDA of N/A
- T2 Biosystems Inc has EV/EBITDA of N/A
- RightCrowd has EV/EBITDA of N/A
- China Strategic has EV/EBITDA of N/A
- Deliveroo Plc has EV/EBITDA of N/A
- Singulus Technologies AG has EV/EBITDA of N/A
- Inventiva S.A has EV/EBITDA of N/A
- Pascal Biosciences has EV/EBITDA of N/A